At first, to formally demonstrate that TGOLN2 had tumour suppressor properties, we selected cell lines with high TGOLN2 levels deriving from tumours for which TGOLN2 was predicted to be a cancer hub. This evidence concerns the gene TGOLN2 and cancer.